Michael Kluk

11.2k citations

53 papers · 4.3k indexed · 1 hit paper · h-index 29

Impact in

Cell Biology top 1%
- Cellular transport and secretion
- Endoplasmic Reticulum Stress and Disease
Hematology top 2%
- Acute Myeloid Leukemia Research

Papers in ⓘ

Molecular Biology 26
- Sphingolipid Metabolism and Signaling 11
- Protein Kinase Regulation and GTPase Signaling 5
Hematology 16
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 5

Co-authors: Timothy Hla (6 shared papers)Nicolas Ancellin (4 shared papers)Shobha Thangada (3 shared papers)Catherine H. Liu (2 shared papers)Kevin P. Claffey (2 shared papers)R.I. Sha’afi (1 shared paper)Mario Volpi (1 shared paper)Ji Hye Paik (1 shared paper)
Journals: Blood (5 papers)Journal of Molecular Diagnostics (3 papers)Molecular Case Studies (2 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Thoracic Oncology (1 paper)
Partner nations: United States Italy Israel

In The Last Decade

Michael Kluk

51 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate 1999 · 864 citations

Peers

Countries citing papers authored by Michael Kluk

Since Specialization

Citations

This map shows the geographic impact of Michael Kluk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kluk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kluk more than expected).

Fields of papers citing papers by Michael Kluk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kluk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kluk. The network helps show where Michael Kluk may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Kluk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Kluk Line = papers co-authored together Michael Kluk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate Cell ·Menq-Jer Lee, Shobha Thangada, Kevin P. Claffey, Nicolas Ancellin, Catherine H. Liu, Michael Kluk, Mario Volpi, R.I. Sha’afi, Timothy Hla Hit paper breakdown →	1999	864
2	Lysophospholipids--Receptor Revelations Science ·Timothy Hla, Menq-Jer Lee, Nicolas Ancellin, Ji Hye Paik, Michael Kluk	2001	459
3	Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease JAMA ·Jessica L. Mega, Willibald Hochholzer, Andrew L. Frelinger, Michael Kluk, Dominick J. Angiolillo, Larry S. Dean, Steven Isserman, William J. Rogers, Christian T. Ruff, Charles F. Contant, Michael Pencina, Benjamin M. Scirica, Janina A. Longtine, Alan D. Michelson, Marc S. Sabatine	2011	279
4	Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Michael Kluk	2002	272
5	NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis Journal of Investigative Dermatology ·Andrew P. South, Karin J. Purdie, Stephen A. Watt, Sam Haldenby, Nicoline Y. den Breems, Michelle Dimon, Sarah T. Arron, Michael Kluk, Jon C. Aster, Angela McHugh, Dylan J. Xue, Jasbani H.S. Dayal, Kim S. Robinson, Hasan Rizvi, Charlotte M. Proby, Catherine Harwood, Irene M. Leigh	2014	245
6	An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma Nature Genetics ·Yotam Drier, Matthew J. Cotton, Kaylyn E. Williamson, Shawn Gillespie, Russell J.H. Ryan, Michael Kluk, Christopher D. Carey, Scott J. Rodig, Lynette M. Sholl, Amir Afrogheh, William C. Faquin, Lurdes Queimado, Jun Qi, Michael J. Wick, Adel K. El‐Naggar, James E. Bradner, Christopher A. Moskaluk, Jon C. Aster, Birgit Knoechel, B Bernstein	2016	224
7	Polycomb repressive complex 2 is required for MLL-AF9 leukemia Proceedings of the National Academy of Sciences ·Tobias Neff, Amit Sinha, Michael Kluk, Nan Zhu, Mohamed H. Khattab, Lauren Stein, Huafeng Xie, Stuart H. Orkin, Scott A. Armstrong	2012	179
8	Role of the Sphingosine 1-Phosphate Receptor EDG-1 in Vascular Smooth Muscle Cell Proliferation and Migration Circulation Research ·Michael Kluk, Timothy Hla	2001	145
9	Discussion Biochemical Pharmacology ·Timothy Hla, M J Lee, Nicolas Ancellin, C H Liu, Shobha Thangada, Brian Thompson, Michael Kluk	1999	143
10	Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation Blood ·Guoqi Zhang, Li Yang, Gab Seok Kim, Kieran P. Ryan, Shulin Lu, Rebekah K. O’Donnell, Katherine Spokes, Nathan I. Shapiro, William C. Aird, Michael Kluk, Kiichiro Yano, Teresa Sánchez	2013	143
11	MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma Oncogene ·Adlai R. Grayson, Erica M. Walsh, Michael J. Cameron, Jernej Godec, Todd Ashworth, Jessica M Ambrose, Alexandra Aserlind, Hongfang Wang, Gérard I. Evan, Michael Kluk, James E. Bradner, Jon C. Aster, Christopher A. French	2013	142
12	Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke Nature Communications ·Gab Seok Kim, Yang Li, Guoqi Zhang, Honggang Zhao, Magdy Selim, Louise D. McCullough, Michael Kluk, Teresa Sánchez	2015	128
13	Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas PLoS ONE ·Michael Kluk, Bjoern Chapuy, Papiya Sinha, Alyssa Roy, Paola Dal Cin, Donna Neuberg, Stefano Monti, Geraldine S. Pinkus, Margaret A. Shipp, Scott J. Rodig	2012	120
14	Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies Journal of Molecular Diagnostics ·Michael Kluk, R. Coleman Lindsley, Jon C. Aster, Neal I. Lindeman, David Szeto, Dimity Hall, Frank C. Kuo	2016	103
15	The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations Journal of the American Medical Informatics Association ·Linda Huang, Helen Fernandes, Hamid Zia, Peyman Tavassoli, Hanna Rennert, David J. Pisapia, Marcin Imieliński, Andrea Sboner, Mark A. Rubin, Michael Kluk, Olivier Elemento	2016	67
16	Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance Leukemia ·Lian Xu, Zachary R. Hunter, Guang Yang, Yang Cao, Xingguang Liu, Robert Manning, Christina Tripsas, J Chen, Christopher J. Patterson, Michael Kluk, Sandra Kanan, Jorge J. Castillo, Neal I. Lindeman, Steven P. Treon	2014	64
17	A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas Cell Reports ·Russell J.H. Ryan, Jelena Petrovic, Dylan M. Rausch, Yeqiao Zhou, Caleb A. Lareau, Michael Kluk, Amanda L. Christie, Winston Y. Lee, Daniel R. Tarjan, Bingqian Guo, Laura K. Donohue, Shawn Gillespie, Valentina Nardi, Ephraim P. Hochberg, Stephen C. Blacklow, David M. Weinstock, Robert B. Faryabi, B Bernstein, Jon C. Aster, Warren S. Pear	2017	60
18	Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms Journal of Clinical Oncology ·Valentina Nardi, Karen M. Winkfield, Chi Young Ok, Andrzej Niemierko, Michael Kluk, Eyal C. Attar, Guillermo Garcia‐Manero, Sa A. Wang, Robert P. Hasserjian	2012	60
19	TCR-dependent transformation of mature memory phenotype T cells in mice Journal of Clinical Investigation ·Xi Wang, Miriam B. F. Werneck, Boris G. Wilson, Hye Jung Kim, Michael Kluk, Christopher S. Thom, Jonathan W. Wischhusen, Julia A. Evans, Jonathan L. Jesneck, Phuong Nguyen, Courtney G. Sansam, Harvey Cantor, Charles W.M. Roberts	2011	57
20	Rosai–Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation Head and Neck Pathology ·Vignesh Shanmugam, Elizabeth Margolskee, Michael Kluk, Tamara Giorgadze, Attilio Orazi	2016	57

About Michael Kluk

Michael Kluk is a scholar working on Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 53 papers that have together received 4.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Sphingolipid Metabolism and Signaling (11 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Genomics and Diagnostics (6 papers), CAR-T cell therapy research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Cell Biology (795 citations), Hematology (516 citations), Molecular Biology (2.9k citations), Genetics (309 citations) and Pathology and Forensic Medicine (454 citations). Michael Kluk has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Timothy Hla, Nicolas Ancellin, Shobha Thangada, Catherine H. Liu, Kevin P. Claffey, R.I. Sha’afi, Mario Volpi, Ji Hye Paik, Jon C. Aster and Teresa Sánchez. Their work appears in journals such as Blood, Journal of Molecular Diagnostics, Molecular Case Studies, Proceedings of the National Academy of Sciences and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact